Introduction Antimicrobial resistance (AMR) is a major global health threat. According to the CDC (2019), over 2.8 million antibiotic-resistant infections and 35,000 deaths occur annually
Introduction Antibiotic-resistant bacteria are a growing global threat, causing longer hospital stays, higher costs, and increased mortality. The rise of multidrug-resistant (MDR), extensively drug-resistant (XDR),
Introduction Invasive fungal infections (IFI) are life-threatening in ICU patients, with rising incidence and persistently high mortality. The increase is linked to complex care needs,
Introduction (Article introduction authored by INCA Editorial Team) Bacterial pneumonia remains a global health challenge with high morbidity and mortality, particularly in vulnerable populations. Community-acquired
Introduction Ventilator-associated pneumonia (VAP) is a common and serious infection in ICU patients who undergo invasive mechanical ventilation for more than 48 hours. It is
Introduction Respiratory distress is the leading cause of NICU admissions. Rapid diagnosis and appropriate treatment are vital for improving outcomes. Mechanical ventilation (MV) is a
Introduction The intensive care unit (ICU) is a fast-paced, high-risk environment where human lives depend on rapid, precise decisions. Despite technological advancements, human and system-related
Introduction Candida species are a major cause of hospital-acquired fungal infections, leading to significant illness and death, especially in critically ill or immunocompromised patients. While
Introduction The rise of antimicrobial resistance, especially among Gram-negative bacteria, has led to the development of new β-lactam/β-lactamase inhibitor (BL/BLI) combinations. Recently approved agents—cefepime/enmetazobactam, aztreonam/avibactam,
Introduction This post-hoc analysis of a multinational ICU study assessed and compared the clinical profiles, microbiological findings, and outcomes of immunosuppressed versus non-immunosuppressed patients with
Introduction The concept of “time is spine” underscores the importance of early (within 24 hours) or ultra-early (within 12 hours) surgical decompression following spinal cord
Introduction The American Thoracic Society, CDC, European Respiratory Society, and IDSA have updated TB treatment guidelines based on recent clinical trial data. In settings with
Introduction Recurrent urinary tract infections (UTIs) are defined as 2 infections in 6 months or 3 in 12 months, with at least 2 weeks of
Introduction Nosocomial lower respiratory tract infections (nLRTIs), including HAP and VAP, remain a major healthcare burden due to high mortality and cost. Traditional culture methods
Introduction Multidrug-resistant organisms (MDROs) are bacteria resistant to at least one antibiotic in three or more antimicrobial categories, posing a serious global health threat. Antimicrobial
Introduction Candidemia and invasive candidiasis continue to pose high morbidity and mortality risks, especially in healthcare settings. With rising fluconazole resistance and limitations of current
Introduction (Article introduction authored by INCA Editorial Team) Sepsis is a life-threatening condition that frequently occurs in ICU patients with major trauma due to their
Introduction (Article introduction authored by INCA Editorial Team) Sepsis, a life-threatening condition caused by a dysregulated immune response to infection, remains a major global health
Introduction (Article introduction authored by INCA Editorial Team) Acinetobacter baumannii complex (ABC), particularly its carbapenem-resistant strains (CRAB), presents a significant challenge due to its high
Introduction Intra-abdominal infections (IAIs) are a significant, often life-threatening condition affecting millions of patients annually, with treatment responsibility typically distributed across various healthcare providers, including
Introduction In recent years, invasive fungal infections have emerged as a significant public health threat, particularly among immunocompromised individuals such as those with HIV/AIDS, uncontrolled
Introduction Invasive fungal diseases (IFD) pose significant morbidity and mortality risks, particularly among immunocompromised patients, but they can also affect non-neutropenic, critically ill adults in
Introduction Healthcare-associated infections (HAIs) are a leading global public health concern, representing the most common adverse events in healthcare. Effective surveillance is crucial for HAI
Introduction Effective treatment of sepsis demands not only the prompt administration of appropriate antimicrobials but also precise dosing to enhance patient survival. Adequate dosing ensures
Introduction Isavuconazole, an advanced generation triazole antifungal, is effective against a wide range of yeasts, molds, and dimorphic fungi. Currently FDA-approved for managing invasive aspergillosis
Introduction Invasive fungal infections (IFIs) pose a significant threat to critically ill children, particularly those with compromised immune systems. Among the most prevalent fungal pathogens
Introduction Nosocomial pneumonia, encompassing hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), is a major cause of mortality among critically ill patients. A growing number of
Introduction (Article introduction authored by ICU Editorial Team) Invasive fungal infections, particularly those caused by moulds, pose significant morbidity and mortality risks. Limited antifungal classes
Introduction (Article introduction authored by ICU Editorial Team) Pulmonary invasive fungal infections (pIFI) disproportionately affect patients with hematological malignancies (HM), primarily due to their underlying
Introduction (Article introduction authored by ICU Editorial Team) In critically ill patients with acute respiratory failure, thoracic imaging plays a crucial role in evaluating disease
